Comprehensive Flow Cytometry Analysis of PEI-Based Transfections for Virus-Like Particle Production.


Journal

Research (Washington, D.C.)
ISSN: 2639-5274
Titre abrégé: Research (Wash D C)
Pays: United States
ID NLM: 101747148

Informations de publication

Date de publication:
2020
Historique:
received: 09 08 2018
accepted: 28 01 2020
entrez: 8 4 2020
pubmed: 8 4 2020
medline: 8 4 2020
Statut: epublish

Résumé

The generation of stable clones for biomolecule production is a common but lengthy and labor-intensive process. For complex molecules, such as viruses or virus-like particles (VLPs), the timeline becomes even more cumbersome. Thus, in the early stages of development, transient production methods serve as a reasonable alternative to stable clone construction. In this work, an investigation of a polyethylenimine- (PEI-) based transfection method for the transient production of Chikungunya (Chik) VLPs, a vaccine candidate molecule, was undertaken. This effort focuses on tracking cell population responses during transfection, understanding how process changes affect these responses, and monitoring patterns in cell performance over the culture duration. Plasmid labeling and VLP staining were employed to comprehensively track cells via flow cytometry and to draw correlations between plasmid DNA (pDNA) uptake and the resulting VLP expression. The method detected high transfection efficiency (≥97%) in all samples tested and demonstrated the capability to track kinetics of plasmid-cell binding. With varied transfection cell concentrations, the pDNA binding kinetics are altered and saturation binding is observed in the lowest cell concentration sample tested in less than 3 hours of incubation. Interestingly, in all samples, the flow cytometry analysis of relative pDNA amount versus VLP expression staining showed that cells which contained fewer pDNA complexes resulted in the highest levels of VLP stain. Finally, to determine the potential breadth of our observations, we compared daily expression patterns of ChikVLP with a reporter, monomeric GFP molecule. The similarities detected suggest the interpretations presented here to likely be more broadly informative and applicable to PEI-based transient production of additional biological products as well.

Identifiants

pubmed: 32259105
doi: 10.34133/2020/1387402
pmc: PMC7094759
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1387402

Informations de copyright

Copyright © 2020 Daniel J. Blackstock et al.

Déclaration de conflit d'intérêts

The authors declare that there is no conflict of interest regarding the publication of this article.

Références

Adv Drug Deliv Rev. 2005 Apr 5;57(5):733-53
pubmed: 15757758
Elife. 2013 Apr 02;2:e00435
pubmed: 23577234
Anal Chem. 2019 May 21;91(10):6430-6434
pubmed: 31034206
Nat Protoc. 2012 Apr 19;7(5):935-45
pubmed: 22517260
Cell Motil Cytoskeleton. 1989;14(1):147-55
pubmed: 2684421
J Virol. 2012 Aug;86(16):8879-83
pubmed: 22647698
Biotechnol Bioeng. 2017 Nov;114(11):2507-2517
pubmed: 28667757
Adv Drug Deliv Rev. 2005 Apr 5;57(5):755-67
pubmed: 15757759
Anal Bioanal Chem. 2010 Aug;397(8):3173-8
pubmed: 20549496
Bioorg Med Chem Lett. 2015 Mar 15;25(6):1171-6
pubmed: 25677659
Nat Med. 2010 Mar;16(3):334-8
pubmed: 20111039
Crit Rev Biotechnol. 2017 Mar;37(2):163-176
pubmed: 26767547
Biotechnol J. 2014 Sep;9(9):1164-74
pubmed: 24604826
Microbiol Rev. 1994 Sep;58(3):491-562
pubmed: 7968923
Methods Mol Biol. 2012;801:13-26
pubmed: 21987244
Mol Ther. 2003 Aug;8(2):255-63
pubmed: 12907148
Genet Vaccines Ther. 2007 Nov 26;5:11
pubmed: 18036259
J Biotechnol. 2007 Feb 1;128(2):268-80
pubmed: 17118475
Lancet. 2014 Dec 6;384(9959):2046-52
pubmed: 25132507
Biotechnol Prog. 2019 Sep;35(5):e2831
pubmed: 31050215
Curr Infect Dis Rep. 2011 Jun;13(3):218-28
pubmed: 21465340
Biotechnol Bioeng. 2008 Feb 15;99(3):721-7
pubmed: 17680657
Theranostics. 2014 Jan 15;4(3):240-55
pubmed: 24505233
Annu Rev Genomics Hum Genet. 2001;2:177-211
pubmed: 11701648
Biotechnol Lett. 2007 May;29(5):677-84
pubmed: 17235486
Vaccine. 2019 May 27;37(24):3142-3145
pubmed: 31060952
Biotechnol Bioeng. 2000 Mar 5;67(5):598-606
pubmed: 10649234

Auteurs

Daniel J Blackstock (DJ)

Vaccine Production Program Lab, Vaccine Research Center, NIAID, NIH, Gaithersburg, MD, USA.

Alvenne Goh (A)

Vaccine Production Program Lab, Vaccine Research Center, NIAID, NIH, Gaithersburg, MD, USA.

Shamitha Shetty (S)

Vaccine Production Program Lab, Vaccine Research Center, NIAID, NIH, Gaithersburg, MD, USA.

Giulia Fabozzi (G)

Vaccine Production Program Lab, Vaccine Research Center, NIAID, NIH, Gaithersburg, MD, USA.

Rong Yang (R)

Vaccine Production Program Lab, Vaccine Research Center, NIAID, NIH, Gaithersburg, MD, USA.

Vera B Ivleva (VB)

Vaccine Production Program Lab, Vaccine Research Center, NIAID, NIH, Gaithersburg, MD, USA.

Richard Schwartz (R)

Vaccine Production Program Lab, Vaccine Research Center, NIAID, NIH, Gaithersburg, MD, USA.

Joseph Horwitz (J)

Vaccine Production Program Lab, Vaccine Research Center, NIAID, NIH, Gaithersburg, MD, USA.

Classifications MeSH